Kuros Biosciences
Kuros Biosurgery develops biomaterials and bioactive biomaterial combination products for indications in trauma, wound and spine.
Kuros Biosciences has raised €18M across 2 funding rounds from 2 investors, most recently a Growth/Late round in Sep 2022. Based in Zurich, Switzerland; founded 2000; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€18M
€17,787,626
Funding rounds
2
Investors
2
distinct backers
Active since
2019-10
latest 2022-09
Funding by year
EUR raised per yearKuros Biosciences — funding by year — interactive chart.
Data table
| Kuros Biosciences — funding by year | |
|---|---|
| 2019 | €12M |
| 2022 | €6.3M |
Signals
High confidenceRaise-next likelihood6
base rate 37% for Growth/Late
- ▼ Past typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood4
base rate 11% (2+ rounds)
- ▼ Old (26y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-16 | Growth/Late | €6.3M | Optiverder B.V,The Netherlands and Pegasus Global Opportunity Fund | View deal → |
| 2019-10-01 | Other | €12M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData